Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

835 public trials 210 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Recruiting

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

NCT07057791

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Cancer, +8 more
Locations
  • University of Miami Miami, Florida, United States
  • University of Maryland Baltimore, Maryland, United States
  • Morristown Medical Center Morristown, New Jersey, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View all 13 locations
View Trial Details
Recruiting

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

NCT06726148

Conditions
Advanced CCNE1-amplified Solid Tumors, Advanced HR+/HER2- Breast Cancer, Breast Diseases, +14 more
Locations
  • University of California LA Los Angeles, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • WA Uni School Of Med St Louis, Missouri, United States
View all 33 locations
View Trial Details
Recruiting

A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor

NCT05194982

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Renmin Hospital of Wuhan University Wuhan, Hubei, China
View Trial Details
Recruiting

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

NCT06892548

Conditions
Advanced Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Precision NextGen Oncology and Research Center Beverly Hills, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • UCLA - David Geffen School of Medicine Santa Monica, California, United States
View all 91 locations
View Trial Details
Recruiting

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

NCT07488923

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +20 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • NYU Langone Health New York, United States
  • Sarah Cannon Research Institute (SCRI) Nashville, Tennessee, United States
  • UT Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Recruiting

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

NCT07531095

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • New York University Cancer Institute New York, United States
  • Baptist Cancer Center Memphis, Tennessee, United States
  • Next Virginia Fairfax, Virginia, United States
  • Adana Sehir Egitim ve Arastirma Hastanesi Adana, Turkey (Türkiye)
View all 27 locations
View Trial Details

Related conditions